Shapoval, O.; Větvička, D.; Patsula, V.; Engstová, H.; Kočková, O.; Konefał, M.; Kabešová, M.; Horák, D.
Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo. Pharmaceutics 2023, 15, 2694.
https://doi.org/10.3390/pharmaceutics15122694
AMA Style
Shapoval O, Větvička D, Patsula V, Engstová H, Kočková O, Konefał M, Kabešová M, Horák D.
Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo. Pharmaceutics. 2023; 15(12):2694.
https://doi.org/10.3390/pharmaceutics15122694
Chicago/Turabian Style
Shapoval, Oleksandr, David Větvička, Vitalii Patsula, Hana Engstová, Olga Kočková, Magdalena Konefał, Martina Kabešová, and Daniel Horák.
2023. "Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo" Pharmaceutics 15, no. 12: 2694.
https://doi.org/10.3390/pharmaceutics15122694
APA Style
Shapoval, O., Větvička, D., Patsula, V., Engstová, H., Kočková, O., Konefał, M., Kabešová, M., & Horák, D.
(2023). Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo. Pharmaceutics, 15(12), 2694.
https://doi.org/10.3390/pharmaceutics15122694